Strategic partnerships Hawthorne Health collaborates with major sponsors and fintech-like network partners, including recent integration with RxE2 to form a large integrated network of community-based clinical trial locations. This presents a sales opportunity to offer complementary services that expand sponsor reach and streamline site networks.

Tech enabled trials The company emphasizes intelligent technology to expand patient access, improve retention, and reduce study costs, supported by a tech stack including continuous delivery, SOC 2 compliance, cloud monitoring, and digital platforms. This creates opportunities to cross-sell advanced consulting, data capture, and security solutions to sponsors and CROs.

Decentralized footprint With 75+ locations nationwide and focus on embedding research within local communities, Hawthorne Health offers a scalable, patient-centric model ideal for sponsors seeking diverse patient populations and decentralized trial capabilities.

Leadership and growth New CEO Josh Rose appointed in early 2024 alongside ongoing growth in a tech-enabled mobile research space signals potential for strategic initiatives, enterprise partnerships, and expanded service lines aligned with sponsor needs and market demand.

Market positioning Revenue in the mid tens of millions and funding of 23M place Hawthorne Health as a mid-size player capable of competing with larger contract research organizations while offering nimble, community-based trial access—a compelling story for sponsors seeking agility and patient diversity.